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Ocular coloboma is a potentially blinding congenital eye malformation caused by failure of optic ﬁssure
closure during early embryogenesis. The optic ﬁssure is a ventral groove that forms during optic cup
morphogenesis, and through which hyaloid artery and vein enter and leave the developing eye,
respectively. After hyaloid artery and vein formation, the optic ﬁssure closes around them. The
mechanisms underlying optic ﬁssure closure are poorly understood, and whether and how this process
is inﬂuenced by hyaloid vessel development is unknown. Here we show that a loss-of-function
mutation in lmo2, a gene speciﬁcally required for hematopoiesis and vascular development, results in
failure of optic ﬁssure closure in zebraﬁsh. Analysis of ocular blood vessels in lmo2 mutants reveals that
some vessels are severely dilated, including the hyaloid vein. Remarkably, reducing vessel size leads to
rescue of optic ﬁssure phenotype. Our results reveal a new mechanism leading to coloboma, whereby
malformed blood vessels interfere with eye morphogenesis.
& 2012 Elsevier Inc. All rights reserved.Introduction
During early stages of eye formation, invagination of the optic
vesicle results in generation of a bilayered optic cup with a groove
along its ventral margin. This groove, named optic ﬁssure (also
known as choroidal ﬁssure or embryonic ﬁssure), provides an
opening through which the hyaloid artery enters and the hyaloid
vein leaves the developing eye. Subsequently, the margins of the
optic cup close around these vessels. In human embryos the optic
ﬁssure closes during the 6–7th weeks of gestation (Barishak,
2001) and in zebraﬁsh embryos the ﬁssure is closed by 2 days
post-fertilization (dpf). Failure of optic ﬁssure closure leaves a gap
named ocular coloboma, which can lead to impaired vision and
even blindness (Chang et al., 2006).
Many genetic perturbations result in failure of optic ﬁssure
closure and, as a result, coloboma (Chang et al., 2006; Gregory-
Evans et al., 2004). Studies in model organisms, primarily mouse
and zebraﬁsh, suggest that such genetic lesions can lead to abnor-
mal dorsoventral patterning of the optic vesicle, reduced expression
of ventral eye or periocular mesenchyme genes, excessive cell
proliferation and tissue fusion defects (Kim et al., 2007; Lupo
et al., 2011; McLaughlin et al., 2007; Mui et al., 2005). Hence,
multiple mechanisms are involved in optic ﬁssure closure under-
scoring the complexity of this process. However, a mechanisticll rights reserved.
l).
.understanding of the process of optic ﬁssure closure is still missing,
and hence it is poorly understood why this process sometimes fails.
In this work we show that ocular blood vessel development is
an important factor that can affect optic ﬁssure closure. Speciﬁ-
cally, we identify zebraﬁsh lmo2 mutants that fail to close the
optic ﬁssure at 2 dpf. Investigation of vasculature in these
mutants demonstrates that some ocular vessels, including vessels
located in the optic ﬁssure, are grossly dilated and integrity of the
vessels appears to be compromised. The increased vessel size is
ﬂow-dependent and underlies the failure of optic ﬁssure closure,
thus identifying a new mechanism leading to coloboma. Together,
our results suggest new roles for Lmo2 in vascular development
and demonstrate how abnormal vascular development interferes
with organ morphogenesis.Materials and methods
Fish lines and genotyping
lmo2vu270 heterozygous carriers were maintained in AB back-
ground. Identiﬁcation of carriers was performed either by crosses
and observation of mutant phenotype in 25% of progeny or
using the following dCAPS (Neff et al., 2002) genotyping protocol:
a 211 bp fragment from lmo2 locus was PCR-ampliﬁed from
genomic DNA using forward primer 5’ GACTGTTTGGTCAGGACG-
GACTCTA 3’ and reverse primer 5’ CCGTTGAGTTTGGTCCACTC 3’.
PCR product was digested with HindIII and run on 3% agarose gel.
Whereas wild-type allele remains uncut, mutant allele is digested
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rx3 4 kb promoter region (Rembold et al., 2006) was cloned into
EcoRV site in pTolDest (Villefranc et al., 2007) to generate rx3-
destination plasmid. Gal4-VP16 coding sequence was inserted
downstream of rx3 promoter by Gateway LR recombination
reaction with pME-Gal4VP16 (Kwan et al., 2007) to generate
rx3:Gal4-VP16 plasmid. Tg(rx3:Gal4-VP16) ﬁsh were generated
by co-injection of rx3:Gal4-VP16 DNA and Tol2 transposase
synthetic RNA as described (Kawakami et al., 2004). Additional
lines used in this work: Tg(UAS:GFP)vu157 (Inbal et al., 2006);
Tg(kdrl:egfp)s843 (Jin et al., 2005); Tg(kdrl:HsHRAS-mCherry)s896
(Chi et al., 2008).
Expression constructs, RNA synthesis and morpholino injection
pCS2-lmo2: total RNA was isolated from 1 dpf wild-type
embryos with TriFast (Peqlab), and lmo2 coding sequence was
ampliﬁed by RT-PCR (SuperScript, Invitrogen) and cloned into
pCS2þ vector between XbaI and EcoRI sites. pCS2-lmo2-C94X:
C94X mutation was introduced by site directed mutagenesis in
pCS2-lmo2. Sequence was conﬁrmed for both constructs and
synthetic capped RNA was prepared by NotI digestion and
transcription with SP6 polymerase (mMESSAGE mMACHINE,
Ambion). MO1-tnnt2a (Sehnert et al., 2002) has been described.
Tissue sectioning and staining
Embryos were ﬁxed in 4% paraformaldehyde overnight at 4 1C,
washed with PBT, dehydrated in EtOH series and embedded in JB4
resin (Polysciences, Inc.) according to manufacturer’s instructions.
4 mm sections were cut with LKB 8800 Ultratome III microtome
and stained with methylene blue—azure II (Humphrey and
Pittman, 1974).
In situ hybridization, antibody labeling and TUNEL
Whole-mount in situ hybridization (ISH) using riboprobes was
performed according to standard protocols. BMPurple (Roche)
was used as blue substrate. For double labeling by ISH and
immunohistochemistry, ﬁrst ISH was carried out using Fast Red
(Roche) as red ﬂuorescent substrate. Subsequently, embryos were
washed with PBT (PBSþ0.1% Tween-20) followed by two 5 min
washes with PBSTX (PBSþ0.1% Tween-20þ0.1% Triton X-100)
and blocked for 2 h at room temperature in 500 ml blocking buffer
(PBSTXþ10% BSAþ1% donkey serum). Incubation with primary
antibody was done overnight at 4 1C in 500 ml blocking buffer.
Embryos were then washed at least 6 times with PBSTX for
30 min and incubated with secondary antibody overnight at 4 1C
in 500 ml incubation buffer (PBSTXþ1% BSAþ0.1% donkey serum).Fig. 1. lmo2 mutant zebraﬁsh embryos. (A and B) Heads of normal (A) and lmo2 mutan
fertilization (hpf) normal (C) and lmo2 mutant (D) embryos labeled for RBC marker gat
coding sequence at the mutation site. (F) Schematic presentation of Lmo2 protein
(G) Quantiﬁcation of rescue of lmo2 mutant phenotypes by injection of RNA encodin
experiments. (***po0.0001).Following six 15 min washes with PBT, embryos were washed with
PBS, mounted in glycerol or agarose and imaged. Primary anti-
bodies used in this work were rabbit anti-GFP at 1:500 (Torrey
Pines Biolabs) and rabbit anti-phospho-Histone H3 at 1:750 (Santa
Cruz). Secondary antibody was Alexa Fluor 488 donkey anti-rabbit
at 1:400 (Jackson ImmunoResearch).
For TUNEL (terminal deoxynucleotidyl transferase dUTP nick
end labeling), embryos were ﬁxed overnight with 4% paraformal-
dehyde at 4 1C, washed with PBT, gradually transferred to MeOH
and kept at 20 1C. Subsequently, embryos were rehydrated with
PBT, permeabilized by incubation in 0.1% Na–Citrate and 10 mg/ml
proteinase K in PBT, washed with PBT and TUNEL reaction was
performed using in situ cell death detection kit, TMR red (Roche)
according to manufacturer’s instructions.
Microangiography and imaging
For microangiography embryos were anesthetized and
injected with 2–3 nl of 2 mg/ml ﬂuorescein isothiocyanate dex-
tran molecular weight 2,000,000 (Sigma). Dextran was injected
into the sinus venosus and embryos were imaged within 30 min.
To block pigmentation when imaging embryos older than 24
hours post-fertilization (hpf), embryos were raised in the pre-
sence of 0.003% N-Phenylthiourea (PTU) (Sigma) from 22 hpf.
Images were acquired using Zeiss LSM 700 confocal microscope
and Discovery.V8 stereomicroscope with Axiocam MRc digital
camera (Zeiss).
Data quantiﬁcation and statistical analysis
Quantiﬁcation of proliferating and apoptotic cells was per-
formed by manually counting labeled cells from single confocal
sections covering the entire depth of the eye. Counted cells were
marked to avoid re-counting of the same cell. Cell counts were
performed independently by two researchers, and results were
highly similar.
We used w2 statistics to test for goodness of ﬁt (rescue experi-
ments) and Student’s t-test (proliferation and cell death experiments).Results
lmo2 mutant zebraﬁsh
To identify new mechanisms underlying failure in optic ﬁssure
closure we searched for mutations causing ocular coloboma
utilizing an F3 ENU-mutagenesis genetic screen. We identiﬁed a
mutant line designated vu270 in which failure of optic ﬁssure
closure was evident at 2 dpf (Fig. 1A and B). Two other pheno-
types observed in the mutants were enlarged, inﬂated-lookingt (B) live embryos at 2 dpf. Arrows point at the optic ﬁssure. (C and D) 30 h post-
a1. (E and E’) Chromatograms showing normal lmo2 (E) and mutant lmo2vu270 (E’)
and the site of predicted truncation in Lmo2 encoded by vu270 allele (arrow).
g normal Lmo2 or Lmo2C94X. Numbers are summary of at least two independent
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situ hybridization for the RBC marker gata1 at 1 dpf conﬁrmed
lack of RBCs in the mutants (Fig. 1C and D). As a ﬁrst step in
identifying the genetic lesion in vu270 ﬁsh, we used available
information on the genetic hierarchy of erythropoiesis (Loose and
Patient, 2006) and examined expression of genes required for
early RBC development. We found that in mutant embryos at 5–7
somite-stage, ﬂi1 and scl were normally expressed whereas gata1
expression was already missing (Suppl. Fig. S1), indicating that
the mutant gene is likely required upstream of gata1. Next, by
positional cloning using simple sequence length polymorphisms
we determined that the mutant locus was on chromosome 18.
A strong candidate gene residing on this chromosome is lmo2,
which encodes a LIM domain only protein essential for early
erythropoiesis upstream of gata1 (Loose and Patient, 2006).
Indeed, polymorphic marker z3853, which maps close to lmo2,
was found to be closely linked to the mutant locus (1.5 cM).
Sequencing lmo2 coding region from mutant embryos revealed a
nonsense mutation whereby T to A transversion generates a stop
codon at position 94 (C94X), the beginning of the second LIM
domain (Fig. 1E,E’,F).
To test whether the mutation in lmo2 caused all observed
phenotypes, we injected synthetic lmo2 RNA into embryos from a
cross between lmo2vu270/þ ﬁsh and assayed these embryos for
rescue of phenotypes. In the uninjected control group, 24.25%
(n¼97/400) showed the mutant phenotype and the remaining
embryos appeared normal. In the experiment group, injection of
as little as 20 pg of synthetic RNA per embryo restored RBC
formation and rescued coloboma, inﬂated head and vascular
abnormalities (see below) in the mutants (mutant phenotype:
3/174, 1.7%; po0.0001; Fig. 1G, Suppl. Fig. S2A and B). In fact,
injected mutant embryos were typically indistinguishable from
normal siblings at least until 2 dpf and we conﬁrmed the presence
of mutants by genotyping. In contrast, injection of synthetic RNA
encoding Lmo2C94X mutant protein at similar or much higher
doses (250 pg per embryo), failed to rescue any of the described
phenotypes (mutant phenotype: 96/343, 28%; p¼0.1; Fig. 1G).
It has been shown that forced expression of a truncated Lmo2
protein missing its second LIM domain in transgenic mice resulted
in decreased hematopoiesis, suggesting that in the absence of the
second LIM domain, Lmo2 functioned as a dominant negative
(Terano et al., 2005). We therefore injected very high doses of
lmo2C94X synthetic RNA into wild-type embryos (750 pg per
embryo), however, we could not detect any abnormal phenotypes
in the injected embryos (Suppl. Fig. S2C and D). Altogether, the
results indicate that eye, head, vasculature and blood phenotypes
result from lmo2vu270 mutation and suggest that the mutant
protein lost its activity.
Abnormal ocular vasculature in lmo2 mutant embryos
The lack of RBCs does not explain the enlarged head and
coloboma phenotypes observed in lmo2 mutants, suggesting that
loss of Lmo2 function results in additional abnormalities, which
underlie these defects. To understand why loss of Lmo2 function
resulted in an inﬂated-looking head and ocular coloboma, we ﬁrst
sectioned and compared heads of 2 dpf mutant and normal
embryos. Transverse sections through the forebrain of mutants
revealed abnormal spaces around the eyes and lenses and within
head tissues (Fig. 2A and B). Additionally, brain ventricles were
grossly inﬂated (Fig. 2A and B). These ﬁndings suggest that
mutant embryos suffer from severe head edema.
Edema could be a consequence of vascular abnormalities, for
example, increased vascular permeability. We therefore examined
ocular blood vessels in live Tg(kdrl:EGFP) embryos whose
endothelial cells express EGFP (Jin et al., 2005). Early embryonicocular vasculature comprises two systems, the intraocular hyaloid
system and a superﬁcial system that gives rise to choroidal
vasculature (Alvarez et al., 2007; Kitambi et al., 2009; Saint-
Geniez and D’Amore, 2004). In normal embryos at 2 dpf, the
hyaloid artery enters the eye through the medially located optic
disk and supplies a network of capillaries that partially envelope
the lens (Fig. 2C and E). The superﬁcial system at this stage
comprises the nasal radial vessel (nrv) through which blood
enters, and the dorsal radial vessel (drv) and ventral radial vessel
(vrv) through which blood drains from the system (Fig. 2E)
(following nomenclature by (Kitambi et al., 2009)). These vessels
are interconnected by a superﬁcial ring-shaped vessel (Fig. 2E).
The hyaloid system drains through a connection to the vrv to
which we refer as hyaloid vein (Fig. 2E). In lmo2 mutant embryos
(n¼5/5), the hyaloid artery appears constricted whereas hyaloid
capillaries and vein appear dilated, with much larger diameters
than normal (Fig. 2C–F). Similarly, superﬁcial ring vessel and vrv
are grossly dilated in the mutants compared to normal siblings
and the ventral parts of the ring vessel which connect to the vrv
form with a delay of several hours (Fig. 2C–F; data not shown).
To ﬁnd whether abnormal vasculature in lmo2 mutant
embryos was the underlying cause for head edema, we assessed
functionality and permeability of ocular blood vessels using
microangiography. We injected high-molecular weight ﬂuores-
cent dextran into the sinus venosus of normal or lmo2 mutant
kdrl:HsHRAS-mCherry transgenic embryos that express mCherry
in endothelial cells (Chi et al., 2008). Consistent with our observa-
tions in kdrl:EGFP transgenic embryos, most ocular vessels
demonstrated by the dye and transgene were grossly dilated in
the mutants compared to normal siblings (n¼3/3; Fig. 2G and H).
Additionally, in the periphery of the mutants’ eyes an abnormal
accumulation of dye was observed, suggesting that vessel perme-
ability and/or integrity was compromised leading to leakage of
dye (Fig. 2G and H). These data suggest that in lmo2 mutant
embryos, ﬂuid ﬂows in ocular vasculature and periocular and
brain edemas are caused by leakage of ﬂuid from blood vessels.
lmo2 is expressed in the developing head vasculature
The abnormal vasculature in lmo2 mutants suggests a role for
Lmo2 in vascular development. Indeed, Lmo2 is known to func-
tion in angiogenesis (Patterson et al., 2007; Yamada et al., 2000;
Yamada et al., 2002), however, its exact roles in this process are
unknown. During early embryogenesis, lmo2 expression has been
reported to be restricted to hematopoietic and endothelial cells
(Gratzinger et al., 2009; Zhu et al., 2005). To ﬁnd whether lmo2 is
expressed in head vasculature, and speciﬁcally in ocular blood
vessels during their development, we studied its expression
pattern in the head, relative to the developing vasculature. We
detected highest levels of lmo2 expression in the head region at
mid-segmentation stages (15–16 somite-stage), in two distinct
regions: a relatively large region just posterior to each eye and a
smaller region medial to the anterior part of each eye (Fig. 3A and B).
The posterior and anterior regions of lmo2 expression correspond to
the location of the recently described clusters of endothelial pre-
cursors that give rise to head vasculature, namely, the midbrain
organizing center (MOC) and rostral organizing center (ROC) (Proulx
et al., 2010), respectively. Indeed, these clusters of endothelial cells
are also the source of ocular vasculature (R. Belaiev, R. K. and A. I.,
unpublished observations).
To conﬁrm that lmo2 transcripts are expressed in developing
head vasculature we co-labeled Tg(kdrl:EGFP) embryos for lmo2
and EGFP expression. The double labeling showed that in the ROC
most endothelial precursors expressed lmo2 (Fig. 3C–E), and in the
MOC only some endothelial precursors expressed lmo2 (Fig. 3F–H).
These results show that lmo2 is expressed in endothelial precursors
Fig. 2. Edema and ocular vessel phenotypes in lmo2 mutant embryos. (A and B) Transverse sections of heads from normal (A) and lmo2 mutant (B) embryos at 2.5 dpf. In
the mutant note enlarged ventricle and white spaces within head and eye (arrow) tissues suggesting severe edema. Asterisks mark brain ventricle. (C and D) Three-
dimensional shadow rendering confocal images of 55–56 hpf Tg(kdrl:EGFP) normal (C) and lmo2 mutant (D) eyes in frontal view. (E and F) Three-dimensional maximum
projection confocal images of 55–56 hpf Tg(kdrl:EGFP) normal (E) and lmo2 mutant (F) eyes in lateral view. Arrows point at different regions of the superﬁcial ring vessel.
(G and H) FITC-dextran microangiography of Tg(kdrl:HsHRAS-mCherry) normal (G) and lmo2 mutant (H) eyes in live embryos at 1.5 dpf, lateral view. Note accumulation of
dye around the mutant eye (arrowheads). drv, dorsal radial vessel; ha, hyaloid artery; hc, hyaloid capillaries; hv, hyaloid vein; nrv, nasal radial vessel; vrv, ventral radial
vessel. In (E–H) anterior is to the left.
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Fig. 3. lmo2 is expressed in the developing head vasculature. (A and B) Whole-
mount in situ hybridization showing lmo2 expression in wild-type embryos.
Arrowheads and arrows point at the ROC and MOC respectively. Asterisks mark
the location of eyes. (C–H) 2 mm single confocal sections of combined in situ
hybridization for lmo2 expression (red) and antibody labeling for EGFP (blue) in
endothelial precursors in Tg(kdrl:EGFP) embryos. lmo2 is expressed in most ROC
(C–E) and in some (arrow) MOC (F–H) endothelial precursors. In (F–H) the
posterior and medial borders of the eye are outlined. All images are of 15–16
somite-stage embryos. (A) Lateral view and (B-H) dorsal view, anterior to the left.
Fig. 4. Optic ﬁssure closure is interrupted at 36 hpf in lmo2 mutant embryos. (A–D)
Transmitted light images of eyes of normal (A and C) and lmo2 mutant (B and D)
embryos at 30 hpf (A and B) and 36 hpf (C and D). Arrows point at the margins of the
optic ﬁssure. All panels are lateral views, anterior to the left.
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blood vessels arise.Closure of the optic ﬁssure begins normally in lmo2 mutants
To gain a better understanding of the coloboma phenotype in
lmo2 mutant embryos we asked whether optic ﬁssure closure was
impaired from the earliest stages, or whether closure of the
ﬁssure began but was subsequently interrupted. We therefore
imaged eyes of normal and lmo2 mutant embryos and measured
the width of the optic ﬁssure at 24 hpf, 30 hpf and 36 hpf, when
closure of the ﬁssure was underway. Images were taken at a focal
plain midway between lateral and medial surfaces of the eye, and
the width of the ﬁssure was measured midway along the
dorsoventral axis of the ﬁssure. At 24 hpf, the average distance
between optic ﬁssure margins was 10–15 mm and no signiﬁcant
difference was observed between normal and mutant embryos
(nnormal¼5 eyes; nmutant¼6 eyes; p¼0.37; data not shown). At
30 hpf, closure of the ﬁssure has started as evidenced by reduced
distance between optic ﬁssure margins (average 4–5 mm), and
still no signiﬁcant difference was observed between normal and
mutant embryos (nnormal¼8 eyes; nmutant¼8 eyes; p¼0.38;
Fig. 4A and B). However, at 36 hpf, whereas optic ﬁssure closure
continued in normal embryos (average distance 1 mm), the dis-
tance between ﬁssure margins was signiﬁcantly increased in
mutant embryos (average distance 7 mm) (nnormal¼8 eyes;
nmutant¼8 eyes; po0.05; Fig. 4C and D). These data indicate that
optic ﬁssure closure commenced normally in lmo2 mutant
embryos, however, after 30 hpf the closure process was inter-
rupted and the ﬁssure reopened.Abnormal blood vessel size interferes with closure of the optic ﬁssure
The reopening of the optic ﬁssure in lmo2 mutant embryos
between 30 and 36 hpf correlates with ﬁrst manifestation of head
edema around 30 hpf, suggesting a possible link between colo-
boma and edema. For example, it is possible that due to effects of
severe edema, cell proliferation or cell death are altered in the
retina, thereby leading to abnormal eye morphogenesis. We
therefore examined whether these processes were affected in
eyes of lmo2 mutant embryos at 30 hpf, just before the coloboma
phenotype becomes apparent. To assess cell proliferation we
labeled embryos with phospho-Histone H3 antibody, a marker
of late G2-M phase, and compared the number of proliferating
cells between normal and mutant eyes. This comparison revealed
that cell proliferation in normal and lmo2 mutant eyes was highly
similar (nnormal¼10 eyes; nmutant¼10 eyes; p¼0.9; Suppl.
Fig. S3A–C). To assess cell death in normal and lmo2 mutant eyes
we used terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) to label apoptotic cells. Consistent with previous
descriptions of cell death in the retina around 30 hpf (Cole and
Ross, 2001; Li et al., 2000), we found few apoptotic cells in the
retina and larger numbers in the lens. Counting apoptotic cells
revealed that the number of dying cells in lmo2 mutant retinas
did not differ signiﬁcantly from their number in normal retinas
(nnormal¼10 eyes; nmutant¼10 eyes; p¼0.65; Suppl. Fig. S3D–F).
These experiments suggest that abnormal cell proliferation or cell
death are not underlying mechanisms leading to failure of optic
ﬁssure closure in lmo2 mutant embryos.
Another possible explanation for coloboma in lmo2 mutant
embryos is that abnormal vasculature was linked to the failure of
optic ﬁssure closure. We hypothesized that in the mutants,
dilated ocular vessels located in the optic ﬁssure interfered with
its closure. To conﬁrm location of dilated vessels in the ﬁssure we
visualized both vasculature and eyes using live normal or lmo2
mutant embryos, carrying kdrl:HsHRAS-mCherry, rx3:Gal4-VP16
and UAS:EGFP (Inbal et al., 2006) transgenes. Imaging these
embryos showed that the hyaloid vein passes through the optic
ﬁssure and connects to the vrv at the ventrolateral margin of the
ﬁssure (n¼3/3; Fig. 5A–C). At 2 dpf, the optic ﬁssure has closed in
normal embryos, whereas in lmo2 mutants the hyaloid vein and
vrv are dilated and the optic ﬁssure is open (n¼3/3; Fig. 5).
Fig. 5. Dilated vessels are located in the optic ﬁssure. (A–F) Three-dimensional shadow rendering of confocal z-stacks of eyes (green) and ocular vessels (red) in 2 dpf
(rx3:Gal4-VP16);(UAS:EGFP);(kdrl:HsHRAS-mCherry) transgenic normal (A–C) and lmo2vu270/vu270 (D–F) embryos. In the merged panels (C and F) most of the hyaloid vessels
cannot be seen. (E and F) Growth of superﬁcial ring vessel is delayed in the mutant (compare to B and C). Arrows point at the optic ﬁssure. Inset in F is a higher
magniﬁcation of the optic ﬁssure area with the arrow pointing at the dilated vessel in the ﬁssure. Vessel abbreviations are as in Fig. 2. All panels are dorsolateral view,
anterior to the left.
Fig. 6. Ocular vessel dilation is ﬂow dependent and interferes with optic ﬁssure closure. (A–D) Single plane confocal images combined with transmitted light image of eyes
of normal Tg(kdrl:EGFP) embryos (A and C) and lmo2vu270/vu270; Tg(kdrl:EGFP) embryos (B,D), uninjected (A and B) or injected with MO1-tnnt2a (C and D). Arrows point at
GFP-positive endothelial cells (green) in close contact with optic ﬁssure margins. (A’–D’) Images of the same embryos as in A–D. Arrows point at optic ﬁssure margins.
Embryos were treated with PTU to block pigmentation. All panels are lateral view, anterior to the left.
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lmo2vu270/vu270 embryos show that endothelial cells are in close
contact with the margins of the open optic ﬁssure (Fig. 6B).
The localization of dilated vessels in the optic ﬁssure and the
close proximity between endothelial cells and ﬁssure margins
support the hypothesis that the enlarged vessels interfered with
ﬁssure closure. To further test this hypothesis, we asked whether a
reduction in vessel diameter could rescue optic ﬁssure closure inlmo2 mutant embryos. We reasoned that blocking blood ﬂowwould
cause a collapse of blood vessels and hence reduced vessel diameter.
To block blood ﬂow we injected embryos with morpholino anti-
sense oligonucleotides (MO) targeting the troponin T2a gene
(tnnt2a; silent heart). tnnt2a is expressed only in the heart and its
loss of function results in failure of heart beating and hence lack of
circulation (Sehnert et al., 2002). At 2 dpf, wild-type or lmo2vu270/þ
embryos injected with MO1-tnnt2a had a slightly reduced head
O. Weiss et al. / Developmental Biology 369 (2012) 191–198 197size, no heartbeat and typical blood accumulation in ventral
trunk vasculature. The optic ﬁssure appeared closed (n¼72/72;
Fig. 6C’). lmo2vu270/vu270 embryos injected with MO1-tnnt2a were
morphologically identical to injected normal siblings, and strikingly,
increased head size and coloboma were no longer observed (n¼27/
27; Fig. 6D’). The mutant embryos could be distinguished from their
normal siblings only by the lack of RBCs. Imaging ocular vessels in
these embryos conﬁrmed that blood vessels passing through the
optic ﬁssure were completely collapsed and optic ﬁssure margins
were closely apposed (Fig. 6D). These results demonstrate that
abnormal dilation of ocular vessels in lmo2 mutant embryos is ﬂow-
dependent and that enlarged vessel size interferes with closure of
the optic ﬁssure.Discussion
Closure of the optic ﬁssure is a poorly understood developmental
process, the failure of which can lead to blindness. Failure to close
the optic ﬁssure is in most cases attributed to abnormalities in
development of the ventral eye or periocular mesenchyme. In this
work we identify zebraﬁsh lmo2 mutants based on their coloboma
phenotype and show that in these mutants, an abnormally enlarged
blood vessel passing through the optic ﬁssure interferes with its
closure, thereby adding a new mechanism that can underlie forma-
tion of coloboma.
lmo2 mutants identiﬁed in this work conﬁrm previously
described roles of Lmo2 and will enable identiﬁcation of new ones.
A critical role for Lmo2 in hematopoiesis is well established. Mouse
embryos homozygous for a knock-out mutation in lmo2 exhibit lack
of erythropoiesis and die around embryonic day 10 because of
severe anemia (Warren et al., 1994). Similarly, zebraﬁsh embryos
injected with antisense morpholino oligonucleotides that interfere
with Lmo2 translation fail to generate RBCs (Patterson et al., 2007).
The early death of lmo2 mutant mouse embryos does not allow
analysis of Lmo2-dependent processes during later embryogenesis,
making the zebraﬁsh mutant that survives for several days, a useful
model for unraveling new roles of Lmo2 in embryonic development.
Interestingly, the vu270 allele, which encodes a truncated
Lmo2 protein that is predicted to lack its second LIM domain,
could be expected to function as a dominant negative. Lmo2
functions as a bridging molecule in transcriptional complexes
required for hematopoiesis, and forced expression in transgenic
mice of a truncated Lmo2 protein missing its second LIM domain
caused reduced hematopoiesis (Terano et al., 2005). In our rescue
experiments, it appears that a higher percentage of embryos show
the mutant phenotype when injected with lmo2C94X synthetic
RNA (Fig. 1G), suggesting that perhaps misexpression of the
mutant protein has a dominant-negative effect. However, statis-
tical analysis of the results does not support a signiﬁcant
difference between the frequency of embryos with mutant
phenotype in the uninjected and injected groups, and genotyping
of all embryos with a mutant phenotype in one of the lmo2C94X-
injected groups demonstrated that all of them (n¼12) were
indeed lmo2vu270/vu270. Moreover, we did not observe any abnor-
mal phenotypes in wild-type embryos injected with very high
amounts of lmo2C94X synthetic RNA, suggesting that the vu270
mutation causes loss of Lmo2 function.
In contrast to its function in hematopoiesis, the role/s of Lmo2
in vascular development are poorly understood. Previous studies
demonstrated a requirement for Lmo2 during vascular develop-
ment. In mice, Lmo2-depleted endothelial cells did not contribute
to angiogenic remodeling during normal development nor to
tumor neo-vascularization (Yamada et al., 2000; Yamada et al.,
2002), demonstrating a requirement for Lmo2 function in angio-
genesis. Studies in zebraﬁsh suggested Lmo2 function is requiredfor arterial differentiation (Patterson et al., 2007). Our ﬁndings
presented in this work suggest that Lmo2-deﬁcient endothelial
cells can function in angiogenesis, since many vessels that form
by angiogenesis are present in the mutants; however, these
vessels are clearly abnormal. Therefore, the newly identiﬁed
lmo2 mutant zebraﬁsh provide a powerful system for identifying
new roles of Lmo2 in blood vessel formation. For example, the
excessive dilation and leakage from some ocular vessels in lmo2
mutants at 1.5–2 dpf suggest that Lmo2 is required for regulation
of vascular permeability and/or integrity. Consistent with a
potential role of Lmo2 in promoting vascular integrity, it has
been shown that it participates in a transcription-regulating
complex that up-regulates VE-Cadherin expression in endothelial
cells (Deleuze et al., 2007). Furthermore, the expression of human
LMO2 has been detected in the vast majority of blood vessels, but
was missing from hepatic sinusoidal endothelium, which is
fenestrated and hence more permeable (Gratzinger et al., 2009).
Thus, the absence of Lmo2 expression might correlate with
increased vessel permeability in speciﬁc contexts.
Interestingly, it appears that not all vessels of the hyaloid and
choroidal systems are similarly affected in lmo2 mutants. Whereas
the hyaloid artery and the nrv appear constricted, other vessels,
namely hyaloid vein, vrv and dorsal region of the superﬁcial ring
vessel are severely dilated. Two possible explanations are that
Lmo2 has different roles in the development of different vessels, or
that in the constricted vessels there is no ﬂow. A differential role
for Lmo2 in different types of blood vessels has been suggested by
the observation that its function is speciﬁcally required for arterial
but not venous differentiation in the zebraﬁsh trunk (Patterson
et al., 2007). Indeed both hyaloid artery and nrv, which are affected
differently from other ocular vessels in lmo2 mutants, function as
arteries. We consider the possibility of lack of ﬂow in some vessels
less likely, since in microangiography experiments dye can be seen
in these vessels (Fig. 2H).
Our data showing that lmo2 is expressed in endothelial precursors
of head vasculature is consistent with a role for Lmo2 in ocular blood
vessel development and might also support the idea that Lmo2 has
different roles in different types of blood vessels. Interestingly, at least
in the MOC, only a subset of endothelial precursors expressed lmo2 at
midsegmentation (Fig. 3H). Hence, the expression of Lmo2 in speciﬁc
endothelial precursors might inﬂuence their cellular properties and
behavior and distinguish them from other endothelial precursors.
More thorough analyses of the effects of Lmo2 expression on
endothelial precursors and the vessels they form are needed to better
understand its speciﬁc roles in vascular development.
In this work we describe a causative link between abnormal
vasculature and coloboma. Failure to close the optic ﬁssure
together with abnormalities in blood vessels have been previously
described, however direct inﬂuence of blood vessels on the optic
ﬁssure has not been shown before. Loss of smoothelin-like function
in zebraﬁsh embryos led to hemorrhaging around the eye and
failure to close the optic ﬁssure, however, no speciﬁc defects in the
vasculature were reported (Kurita et al., 2004). Reduced retinoic
acid signaling in zebraﬁsh leads to coloboma and disrupted hyaloid
vascularization (Lupo et al., 2011), and in adult rats with colobo-
matous anomalies, retinal veins passing along the coloboma were
markedly dilated (Ninomiya et al., 2005). However, in both cases it
is unknown whether there was a causative link between the eye
malformation and vessel abnormalities or if they occurred inde-
pendently. Our results demonstrate that an abnormal blood vessel
passing through the optic ﬁssure can interfere with its closure.
In the case of lmo2 mutants, it appears that this interference is
physical. Whether blood vessels and optic ﬁssure margins interact
through signaling remains an open question. If such an interaction
takes place, it is likely not limited to the development of eyes and
could be relevant to morphogenesis of other organs as well.
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